Hospira

Hospira’s One 2 One® business is a world leader in the custom development and manufacture of parenteral products packaged in vials, prefilled syringes, cartridges, flexible containers and ampoules. Whether your product is a small molecule or advanced biologic, One 2 One’s highly qualified personnel in every world-class facility ensure quality, capacity and security of supply.

Technical Services
One2One is able to manufacture injectable products in a broad range of delivery systems including:

• Vials, bottles and ampoules
• Prefilled glass or plastic syringes
• Cartridges for self-administration devices
• Onco-tain™ cytotoxic containment vial
• Flexible Containers

One2One has the ability to manufacture a variety of injectable products, and has a broad range of capabilities:

• Biologics
• Vaccines
• Beta-lactams
• Cytotoxics
• Controlled Substances
• Potent drugs
• Suspensions
• Emulsions/lips
• Lyophilization
• Sterile Powder Filling
• Terminal Sterilization
• Irradiation Sterilization
• Disposable Compounding Equipment
• Multilingual packaging and labeling
• Cold chain management

Facilities
One2One primarily works with five parenteralmanufacturing facilities in North America, Europeand the Asia Pacific regions, each registeredwith multiple regulatory agencies worldwide:

• McPherson, Kansas, USA: A leader in biologics fill–finish
• Liscate, Italy: Small molecules and biologics fill-finish
• Zagreb, Croatia: Biologics fill-finish
• Chennai, India: Beta-lactam powder filling
• Mulgrave (Melbourne), Australia: Cytotoxic fill–finish